BLFS

BIOLIFE SOLUTIONS INC

BLFS·09062W204·US·Common Stock·Healthcare - Medical Instruments & Supplies-Activist

BLFS (BIOLIFE SOLUTIONS INC) is held by 101 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($116.4M), Invesco Ltd. ($44.8M), VANGUARD CAPITAL MANAGEMENT LLC ($36.6M). Net institutional sentiment: Mixed.

101
Holders
(9 Elite)
$573.7M
Total Value
60% (101)
Consensus
61 buying - 40 selling
13F: Insider & Congress:
BLFS

Smart Money Verdict

View all
Held by 101 funds
9 elite

Who's Trading

ActivistCACasdin Capital, LLC9.7%Jun 4, 2026
ActivistCACasdin Capital, LLC9.7%May 22, 2026
ActivistTRT. Rowe Price Investment Management, Inc.13.5%May 15, 2026
ActivistInvesco Ltd.Invesco Ltd.4.9%May 6, 2026
ActivistThe Vanguard GroupThe Vanguard Group0.0%Mar 26, 2026
InsiderFAFoster Karen A.Sell $49KMar 23, 2026
InsiderFAFoster Karen A.Sell $10KMar 9, 2026
InsiderFAFoster Karen A.Sell $2.0MMar 5, 2026
InsiderMJMathew Aby J.Sell $11KMar 3, 2026
InsiderWTWichterman TroySell $12KMar 3, 2026

Top Holders

Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
6.1M(+3.2%)$116.4M0.0%+30.86%
31
Decreased
2.3M(-40.3%)$44.8M0.0%+35.58%
0
New
1.9M$36.6M0.0%+68.22%
40
Increased
1.6M(+4.8%)$30.1M0.0%+89.76%
30
Decreased
1.5M(-5.0%)$28.1M0.0%+38.09%
0
Increased
1.2M(+19.2%)$22.8M0.0%+41.03%
34
Decreased
1.1M(-0.4%)$20.6M0.1%+4.63%
0
Increased
1M(+1.0%)$19.8M0.0%+59.29%
29
Increased
971,927(+2.0%)$18.5M0.0%+48.56%
29
Increased
904,103(+73.4%)$17.3M0.0%+46.02%
42
Decreased
901,138(-0.3%)$17.2M0.0%+77.26%
0
Increased
885,298(+8.1%)$16.9M0.0%+36.00%
31
New
865,038$16.5M0.0%+68.22%
39
Increased
741,352(+5.0%)$14.1M0.0%+42.92%
29
Increased
584,011(+40.0%)$11.1M0.1%+76.26%
44
Decreased
572,729(-0.5%)$10.9M0.1%+51.57%
0
Decreased
444,228(-17.0%)$8.5M0.0%+51.08%
0
Increased
442,508(+5.7%)$8.4M0.0%+59.89%
29
Increased
444,041(+0.9%)$8.4M0.0%+29.60%
28
Increased
403,485(+6.3%)$7.7M0.0%+36.16%
29

Showing 1-20 of 112

1 / 6
BLFSBLFSBIOLIFE SOLUTIONS INC

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used